Skip to main content
Clinical Trials/CTRI/2023/08/056750
CTRI/2023/08/056750
Recruiting
Phase 3

Safety and efficacy of low dose albumin compared to recommended dose in patients with cirrhosis and spontaneous bacterial peritonitis - Open labelled randomized controlled trial. - MINS study

AIG Hospitals0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K740- Hepatic fibrosis
Sponsor
AIG Hospitals
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient \>18 years age and cirrhosis and ascites with PMN count \>250/cumm in the absence of secondary bacterial peritonitis. Patient with SBP diagnosed in our hospital.

Exclusion Criteria

  • Patients less than 18 years of age
  • Hepatocellular carcinoma or peritoneal carcinomatosis
  • Tuberculosis, pancreatitis or bleeding into ascitic fluid (which can elevate the PMN count in ascitic fluid).
  • Cardiac or end\-stage kidney disease.
  • Patients with SBP diagnosed in outside hospital
  • Secondary bacterial peritonitis.

Outcomes

Primary Outcomes

Not specified

Similar Trials